Research map: Methodological considerations on the predictive value of tumor-infiltrating lymphocytes for pathological complete response in early triple-negative breast cancer

Back to the article

Papers in this map

  1. Quantifying possible bias in clinical and epidemiological studies with quantitative bias analysis: common approaches and limitations · Jeremy Philip Brown · 2024 · 44 citations · Cited by this paper
  2. Retrospective study on regional nodal irradiation after omission of axillary lymph node dissection in sentinel lymph node-positive breast cancer: a propensity score matching analysis · 2026 · Related
  3. Propensity score methods in observational research: brief review and guide for authors · Benjamin Y. Andrew · 2023 · 34 citations · Cited by this paper
  4. Factors influencing discussion duration in breast cancer multidisciplinary team meetings: insights for streamlining care · 2026 · Related
  5. Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimen · Riya Albert · 2026 · 1 citation · Cited by this paper
  6. Antacid co-treatment and pregnane X receptor genetic polymorphisms are survival determinants in patients treated with palbociclib · 2026 · Related
  7. Curative-intent stereotactic ablative body radiation, surgery, and systemic therapy in non-osseous oligometastatic breast cancer · 2026 · Related
  8. Early first-line systemic anticancer therapeutic attrition after metastatic recurrence in triple-negative breast cancer following neoadjuvant chemo-immunotherapy: a multicenter real-world study · 2026 · Related
  9. Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B) · 2026 · Related
  10. Age-stratified difference in patient-reported health-related quality of life following breast cancer surgery · 2026 · Related
  11. Rediscovering the Ciucci pathway: in-vivo evidence of a palmar lymphatic channel · 2026 · Related
  12. Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer · 2026 · Related

Source: OpenAlex (CC0)